CLYM vs. ACM

Last updated Jul 11, 2026

CLYM (Climb Bio Inc) and ACM (AECOM) are both stocks. CLYM operates in Biotechnology (Healthcare), while ACM operates in Engineering & Construction (Industrials). Over the past 3 years, CLYM returned 67.48%/yr vs -6.88%/yr for ACM. At a 0.11 correlation, their price movements are largely independent.

Performance

CLYM vs. ACM - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Climb Bio Inc (CLYM) and AECOM (ACM). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, CLYM achieves a 250.00% return, which is significantly higher than ACM's -27.60% return.

CLYM

• 1D: 1.30%
• 1M: 28.32%
• 6M: 178.33%
• YTD: 250.00%
• 1Y: 921.90%
• 3Y*: 67.48%
• 5Y*: —
• 10Y*: —

ACM

• 1D: 0.29%
• 1M: -2.23%
• 6M: -30.90%
• YTD: -27.60%
• 1Y: -39.57%
• 3Y*: -6.88%
• 5Y*: 2.43%
• 10Y*: 7.73%

*Multi-year figures are annualized to reflect compound growth (CAGR)

CLYM vs. ACM - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021
CLYM Climb Bio Inc	250.00%	122.22%	-33.33%	-26.43%	-64.91%	-35.63%
ACM AECOM	-27.60%	-9.91%	16.67%	9.77%	10.72%	22.08%

Correlation

The correlation between CLYM and ACM is 0.12, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.12
Correlation (3Y) Calculated over the trailing 3-year period	0.09
Correlation (All Time) Calculated using the full available price history since Aug 10, 2021	0.11

Fundamentals

Market Cap CLYM : $954.58M ACM : $8.77B
EPS CLYM : -$0.78 ACM : $3.83
PB Ratio CLYM : 6.45 ACM : 3.93
Total Revenue (TTM) CLYM : $0.00 ACM : $15.99B
Gross Profit (TTM) CLYM : -$106.00K ACM : $1.24B
EBITDA (TTM) CLYM : -$55.93M ACM : $976.83M

Return for Risk

CLYM vs. ACM — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

CLYM

CLYM Risk / Return Rank: 99
CLYM Sharpe Ratio Rank: 100
CLYM Sortino Ratio Rank: 99
CLYM Omega Ratio Rank: 98
CLYM Calmar Ratio Rank: 100
CLYM Martin Ratio Rank: 100

ACM

ACM Risk / Return Rank: 6
ACM Sharpe Ratio Rank: 2
ACM Sortino Ratio Rank: 5
ACM Omega Ratio Rank: 4
ACM Calmar Ratio Rank: 12
ACM Martin Ratio Rank: 8

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

CLYM vs. ACM - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Climb Bio Inc (CLYM) and AECOM (ACM). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	CLYM	ACM	Difference
Sharpe ratio: Return per unit of total volatility	9.65	-1.23	+10.88
Sortino ratio: Return per unit of downside risk	5.56	-1.67	+7.23
Omega ratio: Gain probability vs. loss probability	1.65	0.76	+0.89
Calmar ratio: Return relative to maximum drawdown	27.95	-0.81	+28.76
Martin ratio: Return relative to average drawdown	72.70	-1.42	+74.12

CLYM vs. ACM - Sharpe Ratio Comparison

The current CLYM Sharpe Ratio is 9.65, which is higher than the ACM Sharpe Ratio of -1.23. The chart below compares the historical Sharpe Ratios of CLYM and ACM, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Drawdowns

CLYM vs. ACM - Drawdown Comparison

The maximum CLYM drawdown since its inception was -96.05%, which is greater than ACM's maximum drawdown of -59.97%. Use the drawdown chart below to compare losses from any high point for CLYM and ACM.

Drawdown Indicators

	CLYM	ACM	Difference
Max Drawdown Largest peak-to-trough decline	-96.05%	-59.97%	-36.08%
Max Drawdown (1Y) Largest decline over 1 year	-33.87%	-49.67%	+15.80%
Max Drawdown (3Y) Largest decline over 3 years	-88.92%	-49.67%	-39.25%
Max Drawdown (5Y) Largest decline over 5 years	—	-49.67%	—
Max Drawdown (10Y) Largest decline over 10 years	—	-54.12%	—
Current Drawdown Current decline from peak	-51.07%	-48.63%	-2.44%
Average Drawdown Average peak-to-trough decline	-81.24%	-18.59%	-62.65%
Ulcer Index Depth and duration of drawdowns from previous peaks	13.00%	28.36%	-15.36%

Volatility

CLYM vs. ACM - Volatility Comparison

Climb Bio Inc (CLYM) has a higher volatility of 14.22% compared to AECOM (ACM) at 8.70%. This indicates that CLYM's price experiences larger fluctuations and is considered to be riskier than ACM based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	CLYM	ACM	Difference
Volatility (1M) Calculated over the trailing 1-month period	14.22%	8.70%	+5.52%
Volatility (6M) Calculated over the trailing 6-month period	58.76%	26.93%	+31.83%
Volatility (1Y) Calculated over the trailing 1-year period	98.12%	32.73%	+65.39%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	107.91%	26.76%	+81.15%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	107.91%	31.00%	+76.91%

Dividends

CLYM vs. ACM - Dividend Comparison

CLYM has not paid dividends to shareholders, while ACM's dividend yield for the trailing twelve months is around 1.74%.

Position	TTM	2025	2024	2023	2022
ACM AECOM	1.74%	1.09%	0.82%	0.78%	0.71%
CLYM Climb Bio Inc	0.00%	0.00%	0.00%	0.00%	0.00%

Financials

Frequently Asked Questions

Can I hold both CLYM and ACM in my portfolio?

CLYM and ACM have a correlation of 0.12, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, CLYM or ACM?

CLYM has higher volatility (14.22%) compared to ACM (8.70%). In terms of maximum drawdown, CLYM dropped -96.05% vs ACM's -59.97%.

Which has better risk-adjusted returns?

CLYM currently has the higher Sharpe Ratio (9.65 vs -1.23), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.